Medical Care
Acne Vulgaris Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 546904
- Pages: 126
- Figures: 202
- Views: 1
The global market for Acne Vulgaris Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Acne Vulgaris Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Acne Vulgaris Treatment by region & country, by Type, and by Application.
The Acne Vulgaris Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acne Vulgaris Treatment.
Market Segmentation
By Company
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira Inc
ELORAC Inc
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline Plc
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Novabiotics Ltd
Novan Inc
Novartis AG
Paratek Pharmaceuticals Inc
Pfizer Inc
Phosphagenics Ltd
Segment by Type:
CB-0601
CJM-112
CLS-007
Dapsone
DFD-10
DLX-2323
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Acne Vulgaris Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Acne Vulgaris Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Acne Vulgaris Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Acne Vulgaris Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Acne Vulgaris Treatment by region & country, by Type, and by Application.
The Acne Vulgaris Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acne Vulgaris Treatment.
Market Segmentation
By Company
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira Inc
ELORAC Inc
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline Plc
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Novabiotics Ltd
Novan Inc
Novartis AG
Paratek Pharmaceuticals Inc
Pfizer Inc
Phosphagenics Ltd
Segment by Type:
CB-0601
CJM-112
CLS-007
Dapsone
DFD-10
DLX-2323
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Acne Vulgaris Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Acne Vulgaris Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Acne Vulgaris Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Acne Vulgaris Treatment Product Introduction
1.2 Global Acne Vulgaris Treatment Market Size Forecast
1.3 Acne Vulgaris Treatment Market Trends & Drivers
1.3.1 Acne Vulgaris Treatment Industry Trends
1.3.2 Acne Vulgaris Treatment Market Drivers & Opportunity
1.3.3 Acne Vulgaris Treatment Market Challenges
1.3.4 Acne Vulgaris Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Acne Vulgaris Treatment Players Revenue Ranking (2023)
2.2 Global Acne Vulgaris Treatment Revenue by Company (2019-2024)
2.3 Key Companies Acne Vulgaris Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Acne Vulgaris Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Acne Vulgaris Treatment
2.6 Acne Vulgaris Treatment Market Competitive Analysis
2.6.1 Acne Vulgaris Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Acne Vulgaris Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 CB-0601
3.1.2 CJM-112
3.1.3 CLS-007
3.1.4 Dapsone
3.1.5 DFD-10
3.1.6 DLX-2323
3.1.7 Others
3.2 Global Acne Vulgaris Treatment Sales Value by Type
3.2.1 Global Acne Vulgaris Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Acne Vulgaris Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Acne Vulgaris Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Others
4.2 Global Acne Vulgaris Treatment Sales Value by Application
4.2.1 Global Acne Vulgaris Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Acne Vulgaris Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Acne Vulgaris Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Acne Vulgaris Treatment Sales Value by Region
5.1.1 Global Acne Vulgaris Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Acne Vulgaris Treatment Sales Value by Region (2019-2024)
5.1.3 Global Acne Vulgaris Treatment Sales Value by Region (2025-2030)
5.1.4 Global Acne Vulgaris Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Acne Vulgaris Treatment Sales Value, 2019-2030
5.2.2 North America Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Acne Vulgaris Treatment Sales Value, 2019-2030
5.3.2 Europe Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Acne Vulgaris Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Acne Vulgaris Treatment Sales Value, 2019-2030
5.5.2 South America Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Acne Vulgaris Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Acne Vulgaris Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Acne Vulgaris Treatment Sales Value
6.3 United States
6.3.1 United States Acne Vulgaris Treatment Sales Value, 2019-2030
6.3.2 United States Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Acne Vulgaris Treatment Sales Value, 2019-2030
6.4.2 Europe Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Acne Vulgaris Treatment Sales Value, 2019-2030
6.5.2 China Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Acne Vulgaris Treatment Sales Value, 2019-2030
6.6.2 Japan Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Acne Vulgaris Treatment Sales Value, 2019-2030
6.7.2 South Korea Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Acne Vulgaris Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Acne Vulgaris Treatment Sales Value, 2019-2030
6.9.2 India Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Common Pharma Inc
7.1.1 Common Pharma Inc Profile
7.1.2 Common Pharma Inc Main Business
7.1.3 Common Pharma Inc Acne Vulgaris Treatment Products, Services and Solutions
7.1.4 Common Pharma Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Common Pharma Inc Recent Developments
7.2 Cutanea Life Sciences Inc
7.2.1 Cutanea Life Sciences Inc Profile
7.2.2 Cutanea Life Sciences Inc Main Business
7.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Products, Services and Solutions
7.2.4 Cutanea Life Sciences Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Cutanea Life Sciences Inc Recent Developments
7.3 Dermira Inc
7.3.1 Dermira Inc Profile
7.3.2 Dermira Inc Main Business
7.3.3 Dermira Inc Acne Vulgaris Treatment Products, Services and Solutions
7.3.4 Dermira Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 ELORAC Inc Recent Developments
7.4 ELORAC Inc
7.4.1 ELORAC Inc Profile
7.4.2 ELORAC Inc Main Business
7.4.3 ELORAC Inc Acne Vulgaris Treatment Products, Services and Solutions
7.4.4 ELORAC Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 ELORAC Inc Recent Developments
7.5 Ensol Biosciences Inc
7.5.1 Ensol Biosciences Inc Profile
7.5.2 Ensol Biosciences Inc Main Business
7.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Products, Services and Solutions
7.5.4 Ensol Biosciences Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Ensol Biosciences Inc Recent Developments
7.6 Foamix Pharmaceuticals Ltd
7.6.1 Foamix Pharmaceuticals Ltd Profile
7.6.2 Foamix Pharmaceuticals Ltd Main Business
7.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Products, Services and Solutions
7.6.4 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Foamix Pharmaceuticals Ltd Recent Developments
7.7 Galderma SA
7.7.1 Galderma SA Profile
7.7.2 Galderma SA Main Business
7.7.3 Galderma SA Acne Vulgaris Treatment Products, Services and Solutions
7.7.4 Galderma SA Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Galderma SA Recent Developments
7.8 GlaxoSmithKline Plc
7.8.1 GlaxoSmithKline Plc Profile
7.8.2 GlaxoSmithKline Plc Main Business
7.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Products, Services and Solutions
7.8.4 GlaxoSmithKline Plc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 GlaxoSmithKline Plc Recent Developments
7.9 Helix BioMedix Inc
7.9.1 Helix BioMedix Inc Profile
7.9.2 Helix BioMedix Inc Main Business
7.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Products, Services and Solutions
7.9.4 Helix BioMedix Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Helix BioMedix Inc Recent Developments
7.10 Hovione FarmaCiencia SA
7.10.1 Hovione FarmaCiencia SA Profile
7.10.2 Hovione FarmaCiencia SA Main Business
7.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Products, Services and Solutions
7.10.4 Hovione FarmaCiencia SA Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Hovione FarmaCiencia SA Recent Developments
7.11 Lee's Pharmaceutical Holdings Ltd
7.11.1 Lee's Pharmaceutical Holdings Ltd Profile
7.11.2 Lee's Pharmaceutical Holdings Ltd Main Business
7.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Products, Services and Solutions
7.11.4 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Lee's Pharmaceutical Holdings Ltd Recent Developments
7.12 LEO Pharma A/S
7.12.1 LEO Pharma A/S Profile
7.12.2 LEO Pharma A/S Main Business
7.12.3 LEO Pharma A/S Acne Vulgaris Treatment Products, Services and Solutions
7.12.4 LEO Pharma A/S Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 LEO Pharma A/S Recent Developments
7.13 Novabiotics Ltd
7.13.1 Novabiotics Ltd Profile
7.13.2 Novabiotics Ltd Main Business
7.13.3 Novabiotics Ltd Acne Vulgaris Treatment Products, Services and Solutions
7.13.4 Novabiotics Ltd Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 Novabiotics Ltd Recent Developments
7.14 Novan Inc
7.14.1 Novan Inc Profile
7.14.2 Novan Inc Main Business
7.14.3 Novan Inc Acne Vulgaris Treatment Products, Services and Solutions
7.14.4 Novan Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.14.5 Novan Inc Recent Developments
7.15 Novartis AG
7.15.1 Novartis AG Profile
7.15.2 Novartis AG Main Business
7.15.3 Novartis AG Acne Vulgaris Treatment Products, Services and Solutions
7.15.4 Novartis AG Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.15.5 Novartis AG Recent Developments
7.16 Paratek Pharmaceuticals Inc
7.16.1 Paratek Pharmaceuticals Inc Profile
7.16.2 Paratek Pharmaceuticals Inc Main Business
7.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Products, Services and Solutions
7.16.4 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.16.5 Paratek Pharmaceuticals Inc Recent Developments
7.17 Pfizer Inc
7.17.1 Pfizer Inc Profile
7.17.2 Pfizer Inc Main Business
7.17.3 Pfizer Inc Acne Vulgaris Treatment Products, Services and Solutions
7.17.4 Pfizer Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.17.5 Pfizer Inc Recent Developments
7.18 Phosphagenics Ltd
7.18.1 Phosphagenics Ltd Profile
7.18.2 Phosphagenics Ltd Main Business
7.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Products, Services and Solutions
7.18.4 Phosphagenics Ltd Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.18.5 Phosphagenics Ltd Recent Developments
8 Industry Chain Analysis
8.1 Acne Vulgaris Treatment Industrial Chain
8.2 Acne Vulgaris Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Acne Vulgaris Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Acne Vulgaris Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Acne Vulgaris Treatment Product Introduction
1.2 Global Acne Vulgaris Treatment Market Size Forecast
1.3 Acne Vulgaris Treatment Market Trends & Drivers
1.3.1 Acne Vulgaris Treatment Industry Trends
1.3.2 Acne Vulgaris Treatment Market Drivers & Opportunity
1.3.3 Acne Vulgaris Treatment Market Challenges
1.3.4 Acne Vulgaris Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Acne Vulgaris Treatment Players Revenue Ranking (2023)
2.2 Global Acne Vulgaris Treatment Revenue by Company (2019-2024)
2.3 Key Companies Acne Vulgaris Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Acne Vulgaris Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Acne Vulgaris Treatment
2.6 Acne Vulgaris Treatment Market Competitive Analysis
2.6.1 Acne Vulgaris Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Acne Vulgaris Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 CB-0601
3.1.2 CJM-112
3.1.3 CLS-007
3.1.4 Dapsone
3.1.5 DFD-10
3.1.6 DLX-2323
3.1.7 Others
3.2 Global Acne Vulgaris Treatment Sales Value by Type
3.2.1 Global Acne Vulgaris Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Acne Vulgaris Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Acne Vulgaris Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Others
4.2 Global Acne Vulgaris Treatment Sales Value by Application
4.2.1 Global Acne Vulgaris Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Acne Vulgaris Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Acne Vulgaris Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Acne Vulgaris Treatment Sales Value by Region
5.1.1 Global Acne Vulgaris Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Acne Vulgaris Treatment Sales Value by Region (2019-2024)
5.1.3 Global Acne Vulgaris Treatment Sales Value by Region (2025-2030)
5.1.4 Global Acne Vulgaris Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Acne Vulgaris Treatment Sales Value, 2019-2030
5.2.2 North America Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Acne Vulgaris Treatment Sales Value, 2019-2030
5.3.2 Europe Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Acne Vulgaris Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Acne Vulgaris Treatment Sales Value, 2019-2030
5.5.2 South America Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Acne Vulgaris Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Acne Vulgaris Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Acne Vulgaris Treatment Sales Value
6.3 United States
6.3.1 United States Acne Vulgaris Treatment Sales Value, 2019-2030
6.3.2 United States Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Acne Vulgaris Treatment Sales Value, 2019-2030
6.4.2 Europe Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Acne Vulgaris Treatment Sales Value, 2019-2030
6.5.2 China Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Acne Vulgaris Treatment Sales Value, 2019-2030
6.6.2 Japan Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Acne Vulgaris Treatment Sales Value, 2019-2030
6.7.2 South Korea Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Acne Vulgaris Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Acne Vulgaris Treatment Sales Value, 2019-2030
6.9.2 India Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Acne Vulgaris Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Common Pharma Inc
7.1.1 Common Pharma Inc Profile
7.1.2 Common Pharma Inc Main Business
7.1.3 Common Pharma Inc Acne Vulgaris Treatment Products, Services and Solutions
7.1.4 Common Pharma Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Common Pharma Inc Recent Developments
7.2 Cutanea Life Sciences Inc
7.2.1 Cutanea Life Sciences Inc Profile
7.2.2 Cutanea Life Sciences Inc Main Business
7.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Products, Services and Solutions
7.2.4 Cutanea Life Sciences Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Cutanea Life Sciences Inc Recent Developments
7.3 Dermira Inc
7.3.1 Dermira Inc Profile
7.3.2 Dermira Inc Main Business
7.3.3 Dermira Inc Acne Vulgaris Treatment Products, Services and Solutions
7.3.4 Dermira Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 ELORAC Inc Recent Developments
7.4 ELORAC Inc
7.4.1 ELORAC Inc Profile
7.4.2 ELORAC Inc Main Business
7.4.3 ELORAC Inc Acne Vulgaris Treatment Products, Services and Solutions
7.4.4 ELORAC Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 ELORAC Inc Recent Developments
7.5 Ensol Biosciences Inc
7.5.1 Ensol Biosciences Inc Profile
7.5.2 Ensol Biosciences Inc Main Business
7.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Products, Services and Solutions
7.5.4 Ensol Biosciences Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Ensol Biosciences Inc Recent Developments
7.6 Foamix Pharmaceuticals Ltd
7.6.1 Foamix Pharmaceuticals Ltd Profile
7.6.2 Foamix Pharmaceuticals Ltd Main Business
7.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Products, Services and Solutions
7.6.4 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Foamix Pharmaceuticals Ltd Recent Developments
7.7 Galderma SA
7.7.1 Galderma SA Profile
7.7.2 Galderma SA Main Business
7.7.3 Galderma SA Acne Vulgaris Treatment Products, Services and Solutions
7.7.4 Galderma SA Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Galderma SA Recent Developments
7.8 GlaxoSmithKline Plc
7.8.1 GlaxoSmithKline Plc Profile
7.8.2 GlaxoSmithKline Plc Main Business
7.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Products, Services and Solutions
7.8.4 GlaxoSmithKline Plc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 GlaxoSmithKline Plc Recent Developments
7.9 Helix BioMedix Inc
7.9.1 Helix BioMedix Inc Profile
7.9.2 Helix BioMedix Inc Main Business
7.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Products, Services and Solutions
7.9.4 Helix BioMedix Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Helix BioMedix Inc Recent Developments
7.10 Hovione FarmaCiencia SA
7.10.1 Hovione FarmaCiencia SA Profile
7.10.2 Hovione FarmaCiencia SA Main Business
7.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Products, Services and Solutions
7.10.4 Hovione FarmaCiencia SA Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Hovione FarmaCiencia SA Recent Developments
7.11 Lee's Pharmaceutical Holdings Ltd
7.11.1 Lee's Pharmaceutical Holdings Ltd Profile
7.11.2 Lee's Pharmaceutical Holdings Ltd Main Business
7.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Products, Services and Solutions
7.11.4 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Lee's Pharmaceutical Holdings Ltd Recent Developments
7.12 LEO Pharma A/S
7.12.1 LEO Pharma A/S Profile
7.12.2 LEO Pharma A/S Main Business
7.12.3 LEO Pharma A/S Acne Vulgaris Treatment Products, Services and Solutions
7.12.4 LEO Pharma A/S Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 LEO Pharma A/S Recent Developments
7.13 Novabiotics Ltd
7.13.1 Novabiotics Ltd Profile
7.13.2 Novabiotics Ltd Main Business
7.13.3 Novabiotics Ltd Acne Vulgaris Treatment Products, Services and Solutions
7.13.4 Novabiotics Ltd Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 Novabiotics Ltd Recent Developments
7.14 Novan Inc
7.14.1 Novan Inc Profile
7.14.2 Novan Inc Main Business
7.14.3 Novan Inc Acne Vulgaris Treatment Products, Services and Solutions
7.14.4 Novan Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.14.5 Novan Inc Recent Developments
7.15 Novartis AG
7.15.1 Novartis AG Profile
7.15.2 Novartis AG Main Business
7.15.3 Novartis AG Acne Vulgaris Treatment Products, Services and Solutions
7.15.4 Novartis AG Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.15.5 Novartis AG Recent Developments
7.16 Paratek Pharmaceuticals Inc
7.16.1 Paratek Pharmaceuticals Inc Profile
7.16.2 Paratek Pharmaceuticals Inc Main Business
7.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Products, Services and Solutions
7.16.4 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.16.5 Paratek Pharmaceuticals Inc Recent Developments
7.17 Pfizer Inc
7.17.1 Pfizer Inc Profile
7.17.2 Pfizer Inc Main Business
7.17.3 Pfizer Inc Acne Vulgaris Treatment Products, Services and Solutions
7.17.4 Pfizer Inc Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.17.5 Pfizer Inc Recent Developments
7.18 Phosphagenics Ltd
7.18.1 Phosphagenics Ltd Profile
7.18.2 Phosphagenics Ltd Main Business
7.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Products, Services and Solutions
7.18.4 Phosphagenics Ltd Acne Vulgaris Treatment Revenue (US$ Million) & (2019-2024)
7.18.5 Phosphagenics Ltd Recent Developments
8 Industry Chain Analysis
8.1 Acne Vulgaris Treatment Industrial Chain
8.2 Acne Vulgaris Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Acne Vulgaris Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Acne Vulgaris Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Acne Vulgaris Treatment Market Trends
Table 2. Acne Vulgaris Treatment Market Drivers & Opportunity
Table 3. Acne Vulgaris Treatment Market Challenges
Table 4. Acne Vulgaris Treatment Market Restraints
Table 5. Global Acne Vulgaris Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Acne Vulgaris Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Acne Vulgaris Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Acne Vulgaris Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Acne Vulgaris Treatment
Table 10. Global Acne Vulgaris Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Acne Vulgaris Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Acne Vulgaris Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Acne Vulgaris Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Acne Vulgaris Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Acne Vulgaris Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Acne Vulgaris Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Acne Vulgaris Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Acne Vulgaris Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Acne Vulgaris Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Acne Vulgaris Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Acne Vulgaris Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Acne Vulgaris Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Acne Vulgaris Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Acne Vulgaris Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Acne Vulgaris Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Acne Vulgaris Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Acne Vulgaris Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Acne Vulgaris Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Common Pharma Inc Basic Information List
Table 32. Common Pharma Inc Description and Business Overview
Table 33. Common Pharma Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Common Pharma Inc (2019-2024)
Table 35. Common Pharma Inc Recent Developments
Table 36. Cutanea Life Sciences Inc Basic Information List
Table 37. Cutanea Life Sciences Inc Description and Business Overview
Table 38. Cutanea Life Sciences Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Cutanea Life Sciences Inc (2019-2024)
Table 40. Cutanea Life Sciences Inc Recent Developments
Table 41. Dermira Inc Basic Information List
Table 42. Dermira Inc Description and Business Overview
Table 43. Dermira Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Dermira Inc (2019-2024)
Table 45. Dermira Inc Recent Developments
Table 46. ELORAC Inc Basic Information List
Table 47. ELORAC Inc Description and Business Overview
Table 48. ELORAC Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Acne Vulgaris Treatment Business of ELORAC Inc (2019-2024)
Table 50. ELORAC Inc Recent Developments
Table 51. Ensol Biosciences Inc Basic Information List
Table 52. Ensol Biosciences Inc Description and Business Overview
Table 53. Ensol Biosciences Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Ensol Biosciences Inc (2019-2024)
Table 55. Ensol Biosciences Inc Recent Developments
Table 56. Foamix Pharmaceuticals Ltd Basic Information List
Table 57. Foamix Pharmaceuticals Ltd Description and Business Overview
Table 58. Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Foamix Pharmaceuticals Ltd (2019-2024)
Table 60. Foamix Pharmaceuticals Ltd Recent Developments
Table 61. Galderma SA Basic Information List
Table 62. Galderma SA Description and Business Overview
Table 63. Galderma SA Acne Vulgaris Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Galderma SA (2019-2024)
Table 65. Galderma SA Recent Developments
Table 66. GlaxoSmithKline Plc Basic Information List
Table 67. GlaxoSmithKline Plc Description and Business Overview
Table 68. GlaxoSmithKline Plc Acne Vulgaris Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Acne Vulgaris Treatment Business of GlaxoSmithKline Plc (2019-2024)
Table 70. GlaxoSmithKline Plc Recent Developments
Table 71. Helix BioMedix Inc Basic Information List
Table 72. Helix BioMedix Inc Description and Business Overview
Table 73. Helix BioMedix Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Helix BioMedix Inc (2019-2024)
Table 75. Helix BioMedix Inc Recent Developments
Table 76. Hovione FarmaCiencia SA Basic Information List
Table 77. Hovione FarmaCiencia SA Description and Business Overview
Table 78. Hovione FarmaCiencia SA Acne Vulgaris Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Hovione FarmaCiencia SA (2019-2024)
Table 80. Hovione FarmaCiencia SA Recent Developments
Table 81. Lee's Pharmaceutical Holdings Ltd Basic Information List
Table 82. Lee's Pharmaceutical Holdings Ltd Description and Business Overview
Table 83. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Lee's Pharmaceutical Holdings Ltd (2019-2024)
Table 85. Lee's Pharmaceutical Holdings Ltd Recent Developments
Table 86. LEO Pharma A/S Basic Information List
Table 87. LEO Pharma A/S Description and Business Overview
Table 88. LEO Pharma A/S Acne Vulgaris Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Acne Vulgaris Treatment Business of LEO Pharma A/S (2019-2024)
Table 90. LEO Pharma A/S Recent Developments
Table 91. Novabiotics Ltd Basic Information List
Table 92. Novabiotics Ltd Description and Business Overview
Table 93. Novabiotics Ltd Acne Vulgaris Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Novabiotics Ltd (2019-2024)
Table 95. Novabiotics Ltd Recent Developments
Table 96. Novan Inc Basic Information List
Table 97. Novan Inc Description and Business Overview
Table 98. Novan Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 99. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Novan Inc (2019-2024)
Table 100. Novan Inc Recent Developments
Table 101. Novartis AG Basic Information List
Table 102. Novartis AG Description and Business Overview
Table 103. Novartis AG Acne Vulgaris Treatment Products, Services and Solutions
Table 104. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Novartis AG (2019-2024)
Table 105. Novartis AG Recent Developments
Table 106. Paratek Pharmaceuticals Inc Basic Information List
Table 107. Paratek Pharmaceuticals Inc Description and Business Overview
Table 108. Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 109. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Paratek Pharmaceuticals Inc (2019-2024)
Table 110. Paratek Pharmaceuticals Inc Recent Developments
Table 111. Pfizer Inc Basic Information List
Table 112. Pfizer Inc Description and Business Overview
Table 113. Pfizer Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 114. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Pfizer Inc (2019-2024)
Table 115. Pfizer Inc Recent Developments
Table 116. Phosphagenics Ltd Basic Information List
Table 117. Phosphagenics Ltd Description and Business Overview
Table 118. Phosphagenics Ltd Acne Vulgaris Treatment Products, Services and Solutions
Table 119. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Phosphagenics Ltd (2019-2024)
Table 120. Phosphagenics Ltd Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Acne Vulgaris Treatment Downstream Customers
Table 124. Acne Vulgaris Treatment Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Acne Vulgaris Treatment Product Picture
Figure 2. Global Acne Vulgaris Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Acne Vulgaris Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Acne Vulgaris Treatment Report Years Considered
Figure 5. Global Acne Vulgaris Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Acne Vulgaris Treatment Revenue in 2023
Figure 7. Acne Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. CB-0601 Picture
Figure 9. CJM-112 Picture
Figure 10. CLS-007 Picture
Figure 11. Dapsone Picture
Figure 12. DFD-10 Picture
Figure 13. DLX-2323 Picture
Figure 14. Others Picture
Figure 15. Global Acne Vulgaris Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Acne Vulgaris Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 17. Product Picture of Clinic
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Others
Figure 20. Global Acne Vulgaris Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Acne Vulgaris Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Acne Vulgaris Treatment Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Acne Vulgaris Treatment Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Acne Vulgaris Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Acne Vulgaris Treatment Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Acne Vulgaris Treatment Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Acne Vulgaris Treatment Sales Value (%), (2019-2030)
Figure 33. United States Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 39. China Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 41. China Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. India Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 53. India Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 54. Acne Vulgaris Treatment Industrial Chain
Figure 55. Acne Vulgaris Treatment Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Table 1. Acne Vulgaris Treatment Market Trends
Table 2. Acne Vulgaris Treatment Market Drivers & Opportunity
Table 3. Acne Vulgaris Treatment Market Challenges
Table 4. Acne Vulgaris Treatment Market Restraints
Table 5. Global Acne Vulgaris Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Acne Vulgaris Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Acne Vulgaris Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Acne Vulgaris Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Acne Vulgaris Treatment
Table 10. Global Acne Vulgaris Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Acne Vulgaris Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Acne Vulgaris Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Acne Vulgaris Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Acne Vulgaris Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Acne Vulgaris Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Acne Vulgaris Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Acne Vulgaris Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Acne Vulgaris Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Acne Vulgaris Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Acne Vulgaris Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Acne Vulgaris Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Acne Vulgaris Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Acne Vulgaris Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Acne Vulgaris Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Acne Vulgaris Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Acne Vulgaris Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Acne Vulgaris Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Acne Vulgaris Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Common Pharma Inc Basic Information List
Table 32. Common Pharma Inc Description and Business Overview
Table 33. Common Pharma Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Common Pharma Inc (2019-2024)
Table 35. Common Pharma Inc Recent Developments
Table 36. Cutanea Life Sciences Inc Basic Information List
Table 37. Cutanea Life Sciences Inc Description and Business Overview
Table 38. Cutanea Life Sciences Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Cutanea Life Sciences Inc (2019-2024)
Table 40. Cutanea Life Sciences Inc Recent Developments
Table 41. Dermira Inc Basic Information List
Table 42. Dermira Inc Description and Business Overview
Table 43. Dermira Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Dermira Inc (2019-2024)
Table 45. Dermira Inc Recent Developments
Table 46. ELORAC Inc Basic Information List
Table 47. ELORAC Inc Description and Business Overview
Table 48. ELORAC Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Acne Vulgaris Treatment Business of ELORAC Inc (2019-2024)
Table 50. ELORAC Inc Recent Developments
Table 51. Ensol Biosciences Inc Basic Information List
Table 52. Ensol Biosciences Inc Description and Business Overview
Table 53. Ensol Biosciences Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Ensol Biosciences Inc (2019-2024)
Table 55. Ensol Biosciences Inc Recent Developments
Table 56. Foamix Pharmaceuticals Ltd Basic Information List
Table 57. Foamix Pharmaceuticals Ltd Description and Business Overview
Table 58. Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Foamix Pharmaceuticals Ltd (2019-2024)
Table 60. Foamix Pharmaceuticals Ltd Recent Developments
Table 61. Galderma SA Basic Information List
Table 62. Galderma SA Description and Business Overview
Table 63. Galderma SA Acne Vulgaris Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Galderma SA (2019-2024)
Table 65. Galderma SA Recent Developments
Table 66. GlaxoSmithKline Plc Basic Information List
Table 67. GlaxoSmithKline Plc Description and Business Overview
Table 68. GlaxoSmithKline Plc Acne Vulgaris Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Acne Vulgaris Treatment Business of GlaxoSmithKline Plc (2019-2024)
Table 70. GlaxoSmithKline Plc Recent Developments
Table 71. Helix BioMedix Inc Basic Information List
Table 72. Helix BioMedix Inc Description and Business Overview
Table 73. Helix BioMedix Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Helix BioMedix Inc (2019-2024)
Table 75. Helix BioMedix Inc Recent Developments
Table 76. Hovione FarmaCiencia SA Basic Information List
Table 77. Hovione FarmaCiencia SA Description and Business Overview
Table 78. Hovione FarmaCiencia SA Acne Vulgaris Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Hovione FarmaCiencia SA (2019-2024)
Table 80. Hovione FarmaCiencia SA Recent Developments
Table 81. Lee's Pharmaceutical Holdings Ltd Basic Information List
Table 82. Lee's Pharmaceutical Holdings Ltd Description and Business Overview
Table 83. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Lee's Pharmaceutical Holdings Ltd (2019-2024)
Table 85. Lee's Pharmaceutical Holdings Ltd Recent Developments
Table 86. LEO Pharma A/S Basic Information List
Table 87. LEO Pharma A/S Description and Business Overview
Table 88. LEO Pharma A/S Acne Vulgaris Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Acne Vulgaris Treatment Business of LEO Pharma A/S (2019-2024)
Table 90. LEO Pharma A/S Recent Developments
Table 91. Novabiotics Ltd Basic Information List
Table 92. Novabiotics Ltd Description and Business Overview
Table 93. Novabiotics Ltd Acne Vulgaris Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Novabiotics Ltd (2019-2024)
Table 95. Novabiotics Ltd Recent Developments
Table 96. Novan Inc Basic Information List
Table 97. Novan Inc Description and Business Overview
Table 98. Novan Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 99. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Novan Inc (2019-2024)
Table 100. Novan Inc Recent Developments
Table 101. Novartis AG Basic Information List
Table 102. Novartis AG Description and Business Overview
Table 103. Novartis AG Acne Vulgaris Treatment Products, Services and Solutions
Table 104. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Novartis AG (2019-2024)
Table 105. Novartis AG Recent Developments
Table 106. Paratek Pharmaceuticals Inc Basic Information List
Table 107. Paratek Pharmaceuticals Inc Description and Business Overview
Table 108. Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 109. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Paratek Pharmaceuticals Inc (2019-2024)
Table 110. Paratek Pharmaceuticals Inc Recent Developments
Table 111. Pfizer Inc Basic Information List
Table 112. Pfizer Inc Description and Business Overview
Table 113. Pfizer Inc Acne Vulgaris Treatment Products, Services and Solutions
Table 114. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Pfizer Inc (2019-2024)
Table 115. Pfizer Inc Recent Developments
Table 116. Phosphagenics Ltd Basic Information List
Table 117. Phosphagenics Ltd Description and Business Overview
Table 118. Phosphagenics Ltd Acne Vulgaris Treatment Products, Services and Solutions
Table 119. Revenue (US$ Million) in Acne Vulgaris Treatment Business of Phosphagenics Ltd (2019-2024)
Table 120. Phosphagenics Ltd Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Acne Vulgaris Treatment Downstream Customers
Table 124. Acne Vulgaris Treatment Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Acne Vulgaris Treatment Product Picture
Figure 2. Global Acne Vulgaris Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Acne Vulgaris Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Acne Vulgaris Treatment Report Years Considered
Figure 5. Global Acne Vulgaris Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Acne Vulgaris Treatment Revenue in 2023
Figure 7. Acne Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. CB-0601 Picture
Figure 9. CJM-112 Picture
Figure 10. CLS-007 Picture
Figure 11. Dapsone Picture
Figure 12. DFD-10 Picture
Figure 13. DLX-2323 Picture
Figure 14. Others Picture
Figure 15. Global Acne Vulgaris Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Acne Vulgaris Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 17. Product Picture of Clinic
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Others
Figure 20. Global Acne Vulgaris Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Acne Vulgaris Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Acne Vulgaris Treatment Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Acne Vulgaris Treatment Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Acne Vulgaris Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Acne Vulgaris Treatment Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Acne Vulgaris Treatment Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Acne Vulgaris Treatment Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Acne Vulgaris Treatment Sales Value (%), (2019-2030)
Figure 33. United States Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 39. China Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 41. China Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. India Acne Vulgaris Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Acne Vulgaris Treatment Sales Value by Type (%), 2023 VS 2030
Figure 53. India Acne Vulgaris Treatment Sales Value by Application (%), 2023 VS 2030
Figure 54. Acne Vulgaris Treatment Industrial Chain
Figure 55. Acne Vulgaris Treatment Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232